NO157783C - Fremgangsmaate for fremstilling av et heparinfragment covalent bundet til antitrombin iii, og et mellomprodukt for fremstilling av heparinfragmentforbindelsen. - Google Patents

Fremgangsmaate for fremstilling av et heparinfragment covalent bundet til antitrombin iii, og et mellomprodukt for fremstilling av heparinfragmentforbindelsen.

Info

Publication number
NO157783C
NO157783C NO832092A NO832092A NO157783C NO 157783 C NO157783 C NO 157783C NO 832092 A NO832092 A NO 832092A NO 832092 A NO832092 A NO 832092A NO 157783 C NO157783 C NO 157783C
Authority
NO
Norway
Prior art keywords
preparation
heparin fragment
procedure
intermediate product
compound
Prior art date
Application number
NO832092A
Other languages
English (en)
Norwegian (no)
Other versions
NO832092L (no
NO157783B (no
Inventor
Desire J Collen
Original Assignee
Kabivitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabivitrum Ab filed Critical Kabivitrum Ab
Publication of NO832092L publication Critical patent/NO832092L/no
Publication of NO157783B publication Critical patent/NO157783B/no
Publication of NO157783C publication Critical patent/NO157783C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
NO832092A 1982-06-10 1983-06-09 Fremgangsmaate for fremstilling av et heparinfragment covalent bundet til antitrombin iii, og et mellomprodukt for fremstilling av heparinfragmentforbindelsen. NO157783C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8203611 1982-06-10

Publications (3)

Publication Number Publication Date
NO832092L NO832092L (no) 1983-12-12
NO157783B NO157783B (no) 1988-02-08
NO157783C true NO157783C (no) 1988-05-18

Family

ID=20347038

Family Applications (1)

Application Number Title Priority Date Filing Date
NO832092A NO157783C (no) 1982-06-10 1983-06-09 Fremgangsmaate for fremstilling av et heparinfragment covalent bundet til antitrombin iii, og et mellomprodukt for fremstilling av heparinfragmentforbindelsen.

Country Status (8)

Country Link
US (1) US4623718A (de)
EP (1) EP0098814B1 (de)
JP (1) JPS5925802A (de)
AT (1) ATE22899T1 (de)
CA (1) CA1205011A (de)
DE (2) DE98814T1 (de)
DK (1) DK258283A (de)
NO (1) NO157783C (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3422518A1 (de) * 1984-06-16 1985-12-19 B. Braun Melsungen Ag, 3508 Melsungen Heparin-derivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung bei der behandlung von fettstoffwechselstoerungen
US4859581A (en) * 1986-03-10 1989-08-22 Board Of Regents, The University Of Texas System Endoglycosidase assay
EP0337327A1 (de) * 1988-04-09 1989-10-18 Bioiberica, S.A. Verfahren zur Herstellung von neuen Oligosaccharid-Fragmenten durch kontrollierte chemische Depolymerisation von Heparin
US5252557A (en) * 1988-07-25 1993-10-12 Kiyoshi Kita Administration method of antithrombin
US6491965B1 (en) * 1995-11-30 2002-12-10 Hamilton Civic Hospitals Research Development, Inc. Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US7045585B2 (en) 1995-11-30 2006-05-16 Hamilton Civic Hospital Research Development Inc. Methods of coating a device using anti-thrombin heparin
US6562781B1 (en) 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US20040229778A1 (en) * 2003-05-13 2004-11-18 Elmaleh David R. Pharmaceutical compositions of antithrombin III for the treatment of retroviral diseases
US7498130B2 (en) * 2003-05-13 2009-03-03 Massachusetts General Hospital Method of reducing viral load
US20070196347A1 (en) * 2003-08-12 2007-08-23 Chan Anthony K C Methods for preventing neurological events
CN103743837B (zh) * 2013-12-24 2015-01-21 山东泰邦生物制品有限公司 人抗凝血酶ⅲ肝素结合比例检测方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4301153A (en) 1977-03-21 1981-11-17 Riker Laboratories, Inc. Heparin preparation
JPS6040859B2 (ja) 1977-07-27 1985-09-12 喜温 三浦 抗血栓性人工医療材料
CA1136620A (en) 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
US4351938A (en) 1980-05-19 1982-09-28 Riker Laboratories, Inc. Anticoagulant substance
US4386025A (en) 1980-09-30 1983-05-31 Cutter Laboratories, Inc. Method of preparing antithrombin
US4446126A (en) 1980-09-30 1984-05-01 Cutter Laboratories, Inc. Antithrombin-heparin complex and method for its production
DE3170001D1 (en) * 1980-09-30 1985-05-23 Bayer Ag Method for the production of an antithrombin-heparin complex and pharmaceutical compositions containing the complex
JPS57134419A (en) 1981-02-12 1982-08-19 Eisai Co Ltd Stable anticoagulant of blood
US4526714A (en) 1982-12-13 1985-07-02 Cordis Europa N.V. Conjugates of anticoagulant and protein
US4533549A (en) 1983-01-04 1985-08-06 Lasker Sigmund E Antithrombotic agent
US4689323A (en) 1983-09-26 1987-08-25 Miles Laboratories, Inc. Covalently bound heparin--antithrombin-III complex

Also Published As

Publication number Publication date
ATE22899T1 (de) 1986-11-15
US4623718A (en) 1986-11-18
CA1205011A (en) 1986-05-27
EP0098814B1 (de) 1986-10-15
EP0098814A1 (de) 1984-01-18
NO832092L (no) 1983-12-12
DE3366933D1 (en) 1986-11-20
JPS5925802A (ja) 1984-02-09
NO157783B (no) 1988-02-08
DE98814T1 (de) 1984-06-20
DK258283D0 (da) 1983-06-07
DK258283A (da) 1983-12-11

Similar Documents

Publication Publication Date Title
PT76394B (fr) Procede de preparation de nouveaux conjugues associant par liaison covalente une enzyme et un anticorps
EP0042544A3 (en) Novel antihistamines, process for their preparation and pharmaceutical compositions containing them
FI885142L (fi) Foerfarande och apparatur foer behandling av tyger i en tvaettork.
NO176306C (no) Fremgangsmåte for fremstilling av stjerneformede konjugater
FI892391A7 (fi) Process och anordning foer maskintvaettning av linnetyger medelst en produkt i partikelform.
IT7919700A0 (it) Laminati di vetro e resina sintetica e procedimento per laloro produzione.
DE3650215D1 (de) Orientiertes, silanvernetztes Polyäthylen-Produkt von ultrahohem Molekulargewicht und Verfahren zu dessen Herstellung.
NO882966L (no) Fremgangsmaate for fremstilling av metall-andre fasekompositter og derved fremstilt produkt.
FI73995B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla 6,11-dihydro-dibenso-/b,e/-tiepin-11-n-alkyl- norskopinetrar.
ES8501414A1 (es) Procedimiento de sintesis organica de oligosacaridos
FI892390A0 (fi) Process och anordning foer maskintvaettning av linnetyger medelst en partikelformig produkt och anordning foer utnyttjande av processen.
NO157783C (no) Fremgangsmaate for fremstilling av et heparinfragment covalent bundet til antitrombin iii, og et mellomprodukt for fremstilling av heparinfragmentforbindelsen.
DE3484315D1 (de) Messvorrichtung zur herstellung von nach mass hergestellten artikeln.
IL64292A (en) D-homoandrostane-17alpha-carboxylic acids,derivatives thereof and 17alpha-spiroethers,their manufacture and pharmaceutical compositions containing them
BG40318A3 (en) Method for preparing imunoglobuline derivatives of vindezine
ATE304371T1 (de) Verwendung von staphylococcus enterotoxin homologe für krebs-therapie
NO880179D0 (no) Polymerkomplekser, fremgangsmaate for fremstilling av disse, og farmasoeytiske midler inneholdende disse.
PT73706A (fr) Procede de preparation de nouvelles glycoproteines extraites deklebsiella pneumoniae
FI844732A0 (fi) Produkt, foerfarande och anordning foer att kontrollera sinandet av ett hoelje.
NO175313C (no) Joderte polymerer og deres anvendelse
ATE86251T1 (de) Polycyclische verbindungen, ihre herstellung und sie enthaltende rezepturen.
FI872123L (fi) Foerfarande och anlaeggning foer torkning av ett planformigt material, till exempel enkelt faner.
IL59295A0 (en) Dehydropeptide compounds,their production and pharmaceutical compositions containing them
FI884418A0 (fi) Hjaertskyddande aemne och ett terapeutiskt aemne foer ischemiska sjukdomar omfattande n-innehaollande heterocykliska foereningar, och ett foerfarande foer framstaellning av dessa foereningar.
IT1138155B (it) Composti citostatici,procedimento per la loro preparazione e composizioni farmaceutiche contenenti gli stessi